|
|
|
|
New STOP SCAMS Website Launches
Exit takes much pleasure in announcing the arrival of a new website to help STOP online Nembutal Scammers!
|
- Aim - stop people falling victim to an online Nembutal scam
- Idea - create an online ‘Neighbourhood Watch’ area where everyone has your back
- Reality - no matter how professional a site might look, it will be a scam
- Task - report the scam so that others can be warned & avoid being scammed
|
|
|
New Doxit Podcast - Nembutal
In this week's Podcast, we discuss the controversial use of Nembutal in capital punishment executions in the US.
|
In particular, we examine the argument that prisoners have recently presented to US Courts that death by pentobarbital injection causes flash pulmonary edema.
|
Flash pulmonary edema, they say, constitutes cruel & unusual punishment.
|
And cruel & unusual punishment is prohibited under the 8th Amendment of the US Constitution.
|
- Does Nembutal cause 'flash pulmonary edema' & is this a problem?
- Is Nembutal still the best drug for a peaceful/ reliable death?
The 2nd issue discussed this week is the global move to re-categorise Nembutal so Veterinarians are less likely to die from an overdose.
|
|
|
|
Exit London Online Workshop
13.00 London Time @ Saturday, 15 August 2020
Free - Members of Exit International
|
Discount - Peaceful Pill eHandbook Subscribers
|
Registration Required for everyone attending
|
Registrations close Thursday 13 August.
|
|
|
|
Coming in August 2020
New PPeH Update on the Multi-Drug Protocols
August 2020 Peaceful Pill eHandbook Update - Coming Soon
|
|
|
|
New End of Life Issues Survey
Exit's good colleague in Canberra (Australia), Dr David Swanton, is currently conducting a survey on all matters concerned with end of life choices.
|
David says: 'we will use the survey to gather information on VAD issues and analyse the data so that VAD organisations and governments can make better informed decisions'.
|
To participate in the Ethical Rights' survey, click HERE
|
The survey will be available for completion until the end of August 2020.
|
|
|
US +1 360 961 1333 || NL +31 6 23 82 95 82 || AU/NZ 1300 10 3948 || UK +44 7883 509 765
|
|
|
|